We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Falls Church, VA-based aerospace and defense operator, Northrop Grumman Corporation (NOC - Free Report) supplies a broad array of products and services to the U.S. Department of Defense, including electronic systems, information technology, aircraft, space technology and systems integration services.
Estimate Trend & Surprise History
Investors should note that Zacks Consensus Estimate for the first quarter earnings of $3.63 per share has increased by 0.55% over the last 60 days.
Northrop Grumman has surpassed the Zacks Consensus Estimate in the last four quarters, resulting in a positive average surprise of 16.17%.
Northrop Grumman Corporation Price and EPS Surprise
We have highlighted some of the key details from the just-released announcement below:
Earnings: Northrop Grumman comfortably surpassed earnings estimates. Earnings per share came in at $4.21 compared to the Zacks Consensus Estimate of $3.63.
Revenue: Revenues of $6.74 billion also exceeded the Zacks Consensus Estimate of $6.58 billion.
Key Stats: Aerospace Systems segment witnessed 10% sales growth whereas its Mission Systems segment witnessed 3% growth.
Stock Price: It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on this NOC earnings report later!
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Image: Bigstock
Northrop Grumman (NOC) Tops Q1 Earnings & Revenue Estimates
Falls Church, VA-based aerospace and defense operator, Northrop Grumman Corporation (NOC - Free Report) supplies a broad array of products and services to the U.S. Department of Defense, including electronic systems, information technology, aircraft, space technology and systems integration services.
Estimate Trend & Surprise History
Investors should note that Zacks Consensus Estimate for the first quarter earnings of $3.63 per share has increased by 0.55% over the last 60 days.
Northrop Grumman has surpassed the Zacks Consensus Estimate in the last four quarters, resulting in a positive average surprise of 16.17%.
Northrop Grumman Corporation Price and EPS Surprise
Northrop Grumman Corporation Price and EPS Surprise | Northrop Grumman Corporation Quote
Zacks Rank: Currently, Northrop Grumman Corporation has a Zacks Rank# 2 (Buy) but that could change following its first quarter 2018 earnings report which has just released. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
We have highlighted some of the key details from the just-released announcement below:
Earnings: Northrop Grumman comfortably surpassed earnings estimates. Earnings per share came in at $4.21 compared to the Zacks Consensus Estimate of $3.63.
Revenue: Revenues of $6.74 billion also exceeded the Zacks Consensus Estimate of $6.58 billion.
Key Stats: Aerospace Systems segment witnessed 10% sales growth whereas its Mission Systems segment witnessed 3% growth.
Stock Price: It would be interesting to see how the market reacts to the results during the trading session today.
Check back later for our full write up on this NOC earnings report later!
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>